日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and social determinants of cardiovascular risk in a population with chronic noncommunicable diseases in Maicao, La Guajira, Colombia: 2024

哥伦比亚瓜希拉省迈考地区慢性非传染性疾病人群心血管风险的临床和社会决定因素:2024 年

Angarita-Melo, Paula Tatiana; Panche-Castellanos, Karen; Rizo-Tello, Víctor Zein; Forero-Torres, Ana Yibby; Porras-Ramírez, Alexandra

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期人表皮生长因子受体2阳性乳腺癌:ATEMPT研究的5年结果及相关性分析

Tarantino, Paolo; Tayob, Nabihah; Villacampa, Guillermo; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Garrett, Audrey Merrill; Marcom, P Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Ruddy, Kathryn J; Waks, Adrienne G; DeMeo, Michelle; Burstein, Harold J; Partridge, Ann H; Dell'Orto, Patrizia; Russo, Leila; Krause, Emma; Newhouse, Daniel J; Kurt, Busem Binboğa; Mittendorf, Elizabeth A; Schneider, Bryan; Prat, Aleix; Winer, Eric P; Krop, Ian E; Tolaney, Sara M

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

新辅助Trebananib联合紫杉醇化疗治疗II/III期乳腺癌:适应性随机I-SPY2试验的疗效和生物标志物发现

Albain, Kathy S; Yau, Christina; Petricoin, Emanuel F; Wolf, Denise M; Lang, Julie E; Chien, A Jo; Haddad, Tufia; Forero-Torres, Andres; Wallace, Anne M; Kaplan, Henry; Pusztai, Lajos; Euhus, David; Nanda, Rita; Elias, Anthony D; Clark, Amy S; Godellas, Constantine; Boughey, Judy C; Isaacs, Claudine; Tripathy, Debu; Lu, Janice; Yung, Rachel L; Gallagher, Rosa I; Wulfkuhle, Julia D; Brown-Swigart, Lamorna; Krings, Gregor; Chen, Yunn Yi; Potter, David A; Stringer-Reasor, Erica; Blair, Sarah; Asare, Smita M; Wilson, Amy; Hirst, Gillian L; Singhrao, Ruby; Buxton, Meredith; Clennell, Julia L; Sanil, Ashish; Berry, Scott; Asare, Adam L; Matthews, Jeffrey B; DeMichele, Angela M; Hylton, Nola M; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S; Symmans, W Fraser; Van't Veer, Laura J; Yee, Douglas; Berry, Donald A; Esserman, Laura J

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

循环肿瘤DNA在接受新辅助化疗的高危早期HER2阴性乳腺癌中的临床意义和生物学特性

Magbanua, Mark Jesus M; Brown Swigart, Lamorna; Ahmed, Ziad; Sayaman, Rosalyn W; Renner, Derrick; Kalashnikova, Ekaterina; Hirst, Gillian L; Yau, Christina; Wolf, Denise M; Li, Wen; Delson, Amy L; Asare, Smita; Liu, Minetta C; Albain, Kathy; Chien, A Jo; Forero-Torres, Andres; Isaacs, Claudine; Nanda, Rita; Tripathy, Debu; Rodriguez, Angel; Sethi, Himanshu; Aleshin, Alexey; Rabinowitz, Matthew; Perlmutter, Jane; Symmans, W Fraser; Yee, Douglas; Hylton, Nola M; Esserman, Laura J; DeMichele, Angela M; Rugo, Hope S; van 't Veer, Laura J

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

一种用于预测 HER2 阳性乳腺癌患者对新辅助拉帕替尼联合曲妥珠单抗治疗(不联合化疗)疗效的多参数分子分类器

Veeraraghavan, Jamunarani; Gutierrez, Carolina; De Angelis, Carmine; Davis, Robert; Wang, Tao; Pascual, Tomas; Selenica, Pier; Sanchez, Katherine; Nitta, Hiroaki; Kapadia, Monesh; Pavlick, Anne C; Galvan, Patricia; Rexer, Brent; Forero-Torres, Andres; Nanda, Rita; Storniolo, Anna M; Krop, Ian E; Goetz, Matthew P; Nangia, Julie R; Wolff, Antonio C; Weigelt, Britta; Reis-Filho, Jorge S; Hilsenbeck, Susan G; Prat, Aleix; Osborne, C Kent; Schiff, Rachel; Rimawi, Mothaffar F

Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer

种族、基因表达特征和高危早期乳腺癌患者的临床结局

Kyalwazi, Beverly; Yau, Christina; Campbell, Michael J; Yoshimatsu, Toshio F; Chien, A Jo; Wallace, Anne M; Forero-Torres, Andres; Pusztai, Lajos; Ellis, Erin D; Albain, Kathy S; Blaes, Anne H; Haley, Barbara B; Boughey, Judy C; Elias, Anthony D; Clark, Amy S; Isaacs, Claudine J; Nanda, Rita; Han, Hyo S; Yung, Rachel L; Tripathy, Debasish; Edmiston, Kristen K; Viscusi, Rebecca K; Northfelt, Donald W; Khan, Qamar J; Asare, Smita M; Wilson, Amy; Hirst, Gillian L; Lu, Ruixiao; Symmans, William Fraser; Yee, Douglas; DeMichele, Angela M; van 't Veer, Laura J; Esserman, Laura J; Olopade, Olufunmilayo I

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

一项针对 II 期和 III 期激素受体阳性、HER2 阴性乳腺癌患者的术前来曲唑、依维莫司和卡罗妥昔单抗治疗的 I/II 期研究

Vaklavas, Christos; Stringer-Reasor, Erica M; Elkhanany, Ahmed M; Ryan, Kevin J; Li, Yufeng; Theuer, Charles P; Acosta, Edward P; Wei, Shi; Yang, Eddy S; Grizzle, William E; Forero-Torres, Andres

Comparison between anthropometric measurements and indices to evaluate general and abdominal obesity, Colombia ENSIN 2015

2015年哥伦比亚ENSIN调查中,人体测量指标与指数在评估全身肥胖和腹部肥胖方面的比较

Forero Torres, Ana Yibby; Forero, Luis Carlos

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

既往未接受治疗的晚期经典型霍奇金淋巴瘤老年患者(≥60岁):来自III期ECHELON-1研究的详细分析

Evens, Andrew M; Connors, Joseph M; Younes, Anas; Ansell, Stephen M; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期HER2阳性乳腺癌患者的心脏结局(ATEMPT研究,TBCRC033):一项随机对照试验

Barroso-Sousa, Romualdo; Tarantino, Paolo; Tayob, Nabihah; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Hu, Jiani; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Briccetti, Frederick; Schneider, Bryan; Garrett, Audrey Merrill; Marcom, Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta; Ruddy, Kathryn J; Zheng, Yue; Rosenberg, Shoshana M; Gelber, Richard D; Trippa, Lorenzo; Barry, William; DeMeo, Michelle; Burstein, Harold; Partridge, Ann; Winer, Eric P; Krop, Ian; Tolaney, Sara M